NCT04700202View on ClinicalTrials.gov

Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit

CompletedOBSERVATIONAL
Enrollment

132

Participants

Timeline

Start Date

June 30, 2020

Primary Completion Date

December 15, 2022

Study Completion Date

December 15, 2022

Conditions
Ventilator-associated PneumoniaHospital-acquired Pneumonia
Interventions
OTHER

Observational

Single center, retrospective chart review. Patients admitted to MDMC ICU from 4/1/2017 to 6/30/2020 will be identified through the electronic medical record utilizing ICD codes for HAP and VAP

Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER

NCT04700202 - Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit | Biotech Hunter | Biotech Hunter